| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Simone Mader | |
| Lior Brimberg | |||
| P2860 | cites work | Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. | Q46651668 |
| Inhibition of Aquaporin-4 Improves the Outcome of Ischaemic Stroke and Modulates Brain Paravascular Drainage Pathways. | Q47733635 | ||
| Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis. | Q47789942 | ||
| Determining the Spatial Relationship of Membrane-Bound Aquaporin-4 Autoantibodies by STED Nanoscopy | Q47870931 | ||
| Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica | Q48172406 | ||
| Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis | Q48219268 | ||
| Enhanced expression of aquaporin 4 in human brain with infarction | Q48325351 | ||
| Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes | Q48382828 | ||
| Aquaporin 4 changes in rat brain with severe hydrocephalus | Q48479571 | ||
| Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders | Q48597814 | ||
| Onset of aquaporin-4 expression in the developing mouse brain. | Q48722671 | ||
| Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. | Q48823528 | ||
| Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson's Disease. | Q48875614 | ||
| Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica. | Q50080563 | ||
| Complement activation in patients with neuromyelitis optica. | Q51063863 | ||
| Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. | Q51767352 | ||
| β-Amyloid accumulation in the human brain after one night of sleep deprivation. | Q52597873 | ||
| Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. | Q54558331 | ||
| Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice. | Q55498468 | ||
| Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma | Q57059935 | ||
| The glymphatic pathway in neurological disorders | Q57788282 | ||
| Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases | Q59273782 | ||
| Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases | Q59273794 | ||
| Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat. | Q64986695 | ||
| Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors | Q74169935 | ||
| Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice | Q80724299 | ||
| Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis | Q82449168 | ||
| Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein | Q24555081 | ||
| Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance | Q24563954 | ||
| Aquaporin 4 and neuromyelitis optica | Q24613666 | ||
| A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. | Q24631193 | ||
| IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel | Q24646531 | ||
| Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance | Q24648744 | ||
| Aquaporins and Brain Tumors | Q26745578 | ||
| International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Q26824579 | ||
| Physiological roles of aquaporin-4 in brain | Q26866009 | ||
| Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits | Q27301321 | ||
| The Indispensable Roles of Microglia and Astrocytes during Brain Development | Q28067530 | ||
| The Glymphatic System: A Beginner's Guide | Q28084591 | ||
| The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain | Q28117909 | ||
| Treatment of neuromyelitis optica: state-of-the-art and emerging therapies | Q28245749 | ||
| The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics | Q29614972 | ||
| A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis | Q29615952 | ||
| Oligodendrocytes: biology and pathology | Q30051584 | ||
| Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy | Q30974448 | ||
| Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. | Q31110030 | ||
| NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis | Q33381309 | ||
| Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders | Q33411707 | ||
| Aquaporin 4 correlates with apparent diffusion coefficient and hydrocephalus severity in the rat brain: a combined MRI-histological study | Q33437971 | ||
| Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica | Q33576962 | ||
| Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. | Q33656297 | ||
| Hydrocephalus in neuromyelitis optica | Q33672598 | ||
| Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation | Q33714909 | ||
| A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica | Q33727402 | ||
| Hydrocephalus induces dynamic spatiotemporal regulation of aquaporin-4 expression in the rat brain | Q33739948 | ||
| Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia | Q33804875 | ||
| Aquaporin-4: orthogonal array assembly, CNS functions, and role in neuromyelitis optica. | Q33892339 | ||
| Aquaporins in the brain: from aqueduct to "multi-duct". | Q34005760 | ||
| Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica | Q34338762 | ||
| AQP4 autoantibody assay performance in clinical laboratory service | Q34368662 | ||
| Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. | Q34377212 | ||
| Three distinct roles of aquaporin-4 in brain function revealed by knockout mice | Q34505493 | ||
| Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method | Q34542751 | ||
| The role of aquaporin-4 in synaptic plasticity, memory and disease | Q34552951 | ||
| Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays | Q34963829 | ||
| Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). | Q35052199 | ||
| Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica | Q35234452 | ||
| Aquaporin-4 expression is increased in oedematous human brain tumours. | Q35465645 | ||
| Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet | Q35471502 | ||
| Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica | Q35626822 | ||
| Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders | Q35753620 | ||
| Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO | Q35764733 | ||
| Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. | Q35776490 | ||
| Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. | Q35857869 | ||
| Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord | Q36328228 | ||
| Long non-coding RNAs in corticogenesis: deciphering the non-coding code of the brain | Q36394663 | ||
| Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes. | Q36451210 | ||
| Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder | Q36625760 | ||
| Sporadic obstructive hydrocephalus in Aqp4 null mice. | Q36638956 | ||
| Molecular cloning of a mercurial-insensitive water channel expressed in selected water-transporting tissues | Q36674076 | ||
| Aquaporin water channels in the nervous system. | Q37066291 | ||
| Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms | Q37089692 | ||
| Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica | Q37235868 | ||
| Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain | Q37277317 | ||
| The AQP structure and functional implications | Q37354952 | ||
| AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology. | Q37433008 | ||
| Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells | Q37467723 | ||
| Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. | Q37472990 | ||
| Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro | Q37520888 | ||
| Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum | Q37557777 | ||
| Aquaporins and neurodegenerative diseases. | Q37814121 | ||
| Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica | Q38429895 | ||
| Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses | Q38625492 | ||
| Understanding the functions and relationships of the glymphatic system and meningeal lymphatics | Q38634466 | ||
| Subcellular expression of aquaporin-4 in substantia nigra of normal and MPTP-treated mice | Q38666438 | ||
| Hydrocephalus: the role of cerebral aquaporin-4 channels and computational modeling considerations of cerebrospinal fluid | Q38825774 | ||
| T cell-activation in neuromyelitis optica lesions plays a role in their formation. | Q39039987 | ||
| Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains | Q39148351 | ||
| Pathogenic T cell responses against aquaporin 4. | Q39563633 | ||
| Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen | Q39745877 | ||
| Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. | Q39770767 | ||
| Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies | Q39881740 | ||
| Implications of the aquaporin-4 structure on array formation and cell adhesion. | Q40344417 | ||
| Very high single channel water permeability of aquaporin-4 in baculovirus-infected insect cells and liposomes reconstituted with purified aquaporin-4. | Q41104307 | ||
| The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosis | Q41683003 | ||
| Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. | Q41717152 | ||
| Aquaporin-4 expression in the cerebrospinal fluid in congenital human hydrocephalus. | Q41952763 | ||
| Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation. | Q42164920 | ||
| Impairment of select forms of spatial memory and neurotrophin-dependent synaptic plasticity by deletion of glial aquaporin-4. | Q42487285 | ||
| Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers | Q42942128 | ||
| Potential utility of aquaporin modulators for therapy of brain disorders | Q43225155 | ||
| Establishment of monoclonal antibodies against the extracellular domain that block binding of NMO-IgG to AQP4. | Q44241235 | ||
| Increased seizure threshold in mice lacking aquaporin-4 water channels | Q44839011 | ||
| Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells | Q44901021 | ||
| Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica | Q44945605 | ||
| Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. | Q45060496 | ||
| The "glymphatic" mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation? | Q45985362 | ||
| Chronic ceftriaxone treatment rescues hippocampal memory deficit in AQP4 knockout mice via activation of GLT-1. | Q46214907 | ||
| Glia protein aquaporin-4 regulates aversive motivation of spatial memory in Morris water maze. | Q46219090 | ||
| An open label study of the effects of rituximab in neuromyelitis optica | Q46482210 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| aquaporin | Q623090 | ||
| glymphatic system | Q15474254 | ||
| aquaporin-4 | Q26987778 | ||
| P304 | page(s) | 90 | |
| P577 | publication date | 2019-01-27 | |
| P1433 | published in | Cells | Q27724621 |
| P1476 | title | Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease | |
| P478 | volume | 8 |
| Q89736188 | Altered Waste Disposal System in Aging and Alzheimer's Disease: Focus on Astrocytic Aquaporin-4 |
| Q104570381 | Astroglial cells as neuroendocrine targets in forebrain development: implications for sex differences in psychiatric disease |
| Q92544496 | Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update |
| Q99612681 | Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors |
| Q90070819 | The Medical Management of Cerebral Edema: Past, Present, and Future Therapies |
Search more.